Takeda Pharmaceutical
303 hedge funds and large institutions have $1.06B invested in Takeda Pharmaceutical in 2025 Q1 according to their latest regulatory filings, with 55 funds opening new positions, 112 increasing their positions, 90 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
3% more funds holding
Funds holding: 295 → 303 (+8)
0.06% less ownership
Funds ownership: 4.53% → 4.47% (-0.06%)
Holders
303
Holding in Top 10
–
Calls
$25.9M
Puts
$646K
Top Buyers
| 1 | +$51M | |
| 2 | +$12.5M | |
| 3 | +$10.3M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$7.12M |
| 5 |
BIP
Brandes Investment Partners
La Jolla,
California
|
+$6.91M |
Top Sellers
| 1 | -$41.9M | |
| 2 | -$26.1M | |
| 3 | -$15.6M | |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
-$7.43M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
-$7.21M |
